期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

哌拉西林-舒巴坦引起药疹12例报告 被引量：1

暂未订购
导出
摘要 12例应用哌拉西林-舒巴坦引起药疹及肝功能损害,并对其精心护理,未发生并发症。
作者 张海燕
机构地区 浙江绍兴县中心医院呼吸内科
出处 《海峡药学》 2012年第3期253-254,共2页 Strait Pharmaceutical Journal
关键词 药疹 肝功能损害 护理
分类号 R927.3 [医药卫生—药学]
  • 相关文献

参考文献4

二级参考文献24

  • 1[2]Livermore DM. Determinants of the activity of heta-lactamase inhibitor combinations [ J]. J Antimicrob Chemother, 1993,31(Supp1 A) :9-21
  • 2[3]Fritsche TR, Sader HS, Jones RN, et al. Comparative activity and sectrum of broad-spectrum β-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program(North America: 2001-2002)[J]. Diagn Microbiol Infect Dis, 2003,47:435-440
  • 3[4]Karlowsky JA, Weaver MK, Thornsberry C, et al. C. omparison of four antimicrobial susceptibility testing methods to determine the in vitro antivities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa[J]. J Clin Microbio. 2003,41:3339-3343
  • 4[6]Jonew RN,Kirby JT,Beach ML, et al. Geographic variations in activity of broad-spectrum-bata-lactams against Pseudomonas aeruginosa:summary of the worldwide SENTRY Antimicrobial Surveillance Program(1997-2000) [J]. Diagn Microbiol Infect Dis, 2002,43: 239-243
  • 5[7]Aldridge KE, Ashcraft D, Cambre K, et al. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, prevotella, Fusobacterium,porphyromonas,and peptostrptococcus species[J]. Antimicrob Agents Chemother. 2001,45:1238-1243
  • 6[8]Snydman DR, Jacobus NV, McDermott LA, et al. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1197-2000[J]. Clin Infect Dis. 2002,35(Suppl 1) :S126-134
  • 7[9]Platsouka E,Zissis NP,Portolos J, et al. Bacterial susceptibilities to piperacillin-tazobaetam in a tertiary care hospital: 5-year review[J]. J Chemother. 2003 , 15:27-30
  • 8[10]Livermore DM,Mushtaq S,James D, et al. In vitro activety of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalized patients in the British Isles[J].Int J Antimicrob Agents. 2003,22:14-27
  • 9[11]Harbarth S,Cosgrove S,Carmeli Y,et al. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant Enterococci [J]. Antimicrob Agent Chemother. 2002,46:1619-1628
  • 10[12]Patterson JE, Hardin TC,Kelly CA,et al. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae[J]. Infect Control Hosp Epidemiol,2000,21:455-458

共引文献28

同被引文献14

  • 1谭玲,车宁.药物皮试知识概述[J].中国临床医生杂志,2005,33(2):46-47. 被引量：5
  • 2赵堪兴,杨培增.眼科学[M].第7 版.北京:人民卫生出版社,2010:73.
  • 3高齐富,潘小莉,刘群.青霉素皮试假阴性常见原因浅析[J].中国现代医生,2007,45(10Z):150-150. 被引量：9
  • 4Kaplan AP. Angioedema [J]. World Allergy Organ J, 2008, 1 ( 6 ) : 103.
  • 5Bernard BL. Immunologic Mechanisms of Penicillin Allergy[J]. N Engl J Med, 1966, 275(20) : 1115.
  • 6Saxon A. Immediate Hypersensitivity Reactions to β - Lactam Antibiotics [J]. Reviews of Infectious Diseases, 1983, 5 (s2) :368.
  • 7Management of Persons Who Have a History of Penicillin Allergy. 2015 STD Treatment Guideline [ EB/OL]. www. cdc. gov/std/tg2015/pen - allergy, htm.
  • 8Silviu DF, McPhillips S, Warrington RJ. The frequency of skin test reactions to side-chain penicillin determinants[J]. J Allergy Clin Immu- nol, 1993, 91(3) : 694.
  • 9Lin E, Saxon A, Riedl M. Penicillin allergy : value of including amoxicillin as a determinant in penicillin skin testing [J]. Int Arch Allergy Immunol,2010, 152(4) : 313.
  • 10Gordon L S, Kathleen D, Peter F K. Penicillin allergy: a practical approach to management[J]. CMAJ,1986, 134(12) : 1353.

引证文献1

二级引证文献1

海峡药学
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部